Your session is about to expire
Metformin vs Actos
Introduction
For patients with type 2 diabetes, certain drugs that alter the concentration of glucose in the blood can help in managing high sugar levels and related symptoms. Metformin and Actos are two such drugs that are prescribed for this condition. They each impact different pathways in the body, but both have a glucose-lowering effect on patients with diabetes. Metformin is classified as a biguanide that works by reducing liver glucose production and improving insulin sensitivity. On the other hand, Actos falls under thiazolidinediones class which primarily works by increasing peripheral insulin sensitivity thereby allowing more efficient use of insulin by muscles and fat cells.
Metformin vs Actos Side By Side
| Attribute | Glucophage | Actos |
|---|---|---|
| Brand Name | Glucophage | Actos |
| Contraindications | Severe kidney disease or on dialysis. Risk of lactic acidosis. | Type-1 diabetes or diabetic ketoacidosis. Not for patients with severe heart failure. |
| Cost | For the brand name version, 100 tablets of 500 mg fall between $270 and $400. Generic metformin costs start as low as $.10-.40 cents per tablet. | For the brand name version, 60 tablets of 30 mg average around $600. Generic pioglitazone costs range from as low as $.50–$2 per tablet. |
| Generic Name | Metformin | Pioglitazone |
| Most Serious Side Effect | Lactic acidosis | Heart failure and bladder cancer |
| Severe Drug Interactions | Not specified in the text, but it's important to avoid hazardous interactions by informing healthcare providers about all medicines being taken. | Not specified in the text, but similar caution as with Metformin regarding informing healthcare providers about all medicines being taken. |
| Typical Dose | Starts at 500 mg twice a day or 850 mg once a day, not to exceed 2000-2500mg per day. | Typically started at 15 or 30 mg once daily, up to a maximum of 45 mg/day. |
What is Metformin?
Metformin (the generic name for Glucophage among others) was one of the first oral medications approved by the FDA for the treatment of type 2 diabetes in 1995. Metformin primarily works by decreasing glucose production in the liver and improving insulin sensitivity, hence lowering blood sugar levels. It is prescribed as a first-line therapy for managing type 2 diabetes due to its efficacy, safety profile, cost-effectiveness, and potential benefits on cardiovascular outcomes.
On another hand, Pioglitazone (Actos), an anti-diabetic medication from a newer class called thiazolidinediones or TZDs that was approved by FDA in 1999. Actos enhances responsiveness to insulin by acting on fat cells, muscle tissue and liver which resultantly reduces glucose production and increases glucose disposal in these tissues. However unlike metformin which has negligible effects on body weight or may cause slight weight loss , pioglitazone can sometimes lead to significant weight gain while it also carries a risk of fluid retention leading to congestive heart failure.
While both drugs have proven effective at managing blood sugar levels in people with type 2 diabetes; they work through different mechanisms and have different side effect profiles which necessitates careful consideration based upon individual patient's condition before prescribing either drug.
What conditions is Metformin approved to treat?
Metformin and Actos are both approved for the treatment of different types of diabetes:
-
Metformin is primarily used to treat type 2 diabetes, and it can be used alone or in combination with other medications. It is also utilized in the management of polycystic ovary syndrome (PCOS).
-
Actos, on the other hand, is specifically approved for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. This medication may be used alone or combined with other antidiabetic medicines.
How does Metformin help with these illnesses?
Metformin assists in managing type 2 diabetes by decreasing the amount of glucose (sugar) produced by your liver and increasing your body’s sensitivity to insulin. It accomplishes this by inhibiting a process called gluconeogenesis, where the liver produces new glucose from non-carbohydrate sources, therefore keeping blood sugar levels more stable over time. Glucose is our primary source of energy and is controlled by insulin — a hormone that allows cells to take in glucose. In those with type 2 diabetes, their bodies either resist the effects of insulin or don't produce enough which leads to elevated blood sugar levels. By reducing glucose production and enhancing insulin sensitivity, Metformin can limit the negative effects of high blood sugar and help patients manage their condition effectively.
What is Actos?
Actos is a brand name for pioglitazone, which belongs to the class of drugs known as thiazolidinediones. Its main function is to improve insulin sensitivity in cells, resulting in better glucose control. It does this by binding with peroxisome proliferator-activated receptors (PPARs) found in fat cells and muscle tissue, thus promoting better utilization and storage of blood glucose. Actos was first approved by the FDA in 1999.
Unlike metformin, which primarily decreases hepatic glucose production and increases insulin sensitivity in the liver, Actos works mainly on peripheral tissues to increase insulin sensitivity. This difference makes pioglitazone's side-effect profile distinct from that of metformin; it can cause weight gain due to fluid retention and increased risk of bone fractures, but it doesn't typically lead to gastrointestinal issues commonly associated with metformin use such as diarrhea or nausea. The ability of Actos to target peripheral tissues might make it an especially useful treatment option for certain individuals with type 2 diabetes who do not respond well or cannot tolerate other oral antidiabetic drugs like Metformin.
What conditions is Actos approved to treat?
Actos, which is also known by its generic name Pioglitazone, has been approved for the treatment of:
- Type 2 diabetes mellitus It works to improve blood sugar control in adults when diet and exercise alone does not manage it effectively. Actos operates by helping your body respond more efficiently to insulin produced by your pancreas.
How does Actos help with these illnesses?
Pioglitazone, also known as Actos, is a type of medication used to treat Type 2 diabetes by regulating blood sugar levels. It works primarily by making the body's cells more sensitive to insulin, a hormone that regulates glucose absorption and utilization. This action allows glucose in the bloodstream to enter cells more effectively thereby reducing overall blood sugar levels. Unlike metformin, which decreases glucose production and improves its usage by your liver and muscles, Actos directly targets your body's resistance to insulin at the cellular level. In some cases where patients may not respond adequately or tolerate metformin well due to gastrointestinal side effects, Actos could be considered an alternative or it can be combined with metformin for enhanced therapeutic effect in controlling blood sugars.
How effective are both Metformin and Actos?
Both metformin and pioglitazone (Actos) have proven track records in managing type 2 diabetes, with FDA approvals coming within a few years of each other. They work through different mechanisms to control blood sugar levels, which means they may be prescribed under varying scenarios. Metformin primarily works by decreasing glucose production in the liver and improving insulin sensitivity in muscle tissue, whereas Actos makes cells more responsive to the insulin already present.
In a head-to-head study conducted in 2005, both drugs demonstrated similar effectiveness at controlling blood sugar levels over a period of six months. However, patients taking Actos experienced slightly more weight gain and edema than those on metformin.
A comprehensive review carried out in 2012 revealed that metformin is effective from the outset of treatment with minimal side effects apart from gastrointestinal issues during initial use. It is well-tolerated across all age groups including elderly populations due to its safety profile. Metformin has grown into one of the most commonly prescribed antidiabetic medications worldwide because it also offers additional benefits such as reduced cardiovascular risk.
On the other hand, according to an extensive meta-analysis done in 2018, Actos appears efficacious for type 2 diabetes management compared to placebo and on par with many other oral hypoglycemic agents. Nevertheless, due to potential side effects like weight gain and heart failure exacerbation particularly among high-risk individuals or when used long-term at higher doses; it's typically considered after metformin therapy either alone or combined with another agent like sulfonylurea.
Substantial research involves using Actos along with first-line treatments such as metformin so confirming its standalone efficacy data is less robust than that for metformin but still promising nonetheless. Because of their distinct pharmacological properties though; Actos could potentially serve better for certain individuals who cannot tolerate metformins' gastrointestinal adverse events or whose bodies resist insulin despite adequate production - something quite common among obese diabetics.
Related trials for metformin and actos
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Metformin typically prescribed?
Oral dosages of Metformin for adults generally start at 500 mg twice a day or 850 mg once a day, gradually increasing as needed to improve blood sugar control. On the other hand, Actos is typically started at 15 or 30 mg once daily for adults. For both medications, it's crucial to monitor blood sugar levels regularly and adjust doses accordingly under medical supervision. The maximum recommended dose per day for Metformin should not exceed 2000-2500mg while for Actos it is around 45mg/day.
At what dose is Actos typically prescribed?
Actos treatment is typically initiated at a dosage of 15–30 mg/day. The dosage can then be increased to 45 mg/day, administered as one single dose, if necessary. However, the maximum recommended daily dose is limited to 45 mg. It's important to note that Actos should not be used for patients with type-1 diabetes or diabetic ketoacidosis and it may take several weeks before any noticeable improvement in blood sugar control is seen after starting on Actos. Always adhere strictly to your doctor's instructions when adjusting dosages of such medications.
What are the most common side effects for Metformin?
Patients on metformin often experience side effects such as:
- Nausea, vomiting
- Diarrhea, flatulence (gas)
- Anorexia (loss of appetite)
- General weakness and fatigue
- Metallic taste in the mouth
- Hypoglycemia (low blood sugar)
On the other hand, those taking Actos may encounter:
- Upper respiratory tract infection
- Headache
- Sinusitis (inflammation of the sinus cavities in the head)
- Muscle pain
- Tooth problems -Swelling from fluid retention
It is important to note that while these are some common side effects associated with each medication, not everyone will experience them. It's also possible for individuals to experience other symptoms not listed here. Always consult with your healthcare provider for personalized advice.
Are there any potential serious side effects for Metformin?
While Metformin and Actos are both used in the treatment of type 2 diabetes, they can come with different potential side effects. When taking Metformin, some patients may experience:
- Hypoglycemia (low blood sugar), which can cause symptoms like dizziness, trembling, sweating or blurred vision
- Allergic reactions such as skin rash, itching or hives
- Lactic acidosis (a buildup of lactic acid in the body), signaled by muscle pain or weakness; numb or cold arms and legs; trouble breathing; stomach pain; nausea with vomiting
- Low vitamin B12 levels - Symptoms include feeling very tired, weak or shortness of breath
Actos on the other hand has its own set of potentially severe side effects including:
- Heart failure: shortness of breath that worsens when lying down; swelling in your feet and ankles
- Bladder cancer: symptoms include blood in urine; painful urination
- Bone fractures: usually affecting women more than men
- Vision problems due to swelling or damage to the back part of the eye
If you experience any extreme side effects from these medications it's crucial to seek medical attention right away.
What are the most common side effects for Actos?
Actos, like many medications, can present a range of side effects including:
- Headache and muscle pain
- Tooth problems
- Sore throat or stuffy nose
- Sinusitis or upper respiratory tract infection
- Fluid retention leading to swelling in the feet or legs
- Weight gain
- Increased risk of bone fracture in women It's crucial to note that while these are common side effects, serious complications such as bladder cancer have been associated with extended use of Actos. Therefore it is recommended for short term use and under careful monitoring by your healthcare provider.
Are there any potential serious side effects for Actos?
Actos, while generally safe and effective for most people, can in rare instances cause severe side effects. Some of the potential adverse reactions to look out for include:
- Signs indicative of an allergic reaction: these could range from hives or itching to fever and swelling in your face or throat. If you experience difficulty breathing coupled with a swollen tongue or throat, seek immediate medical attention.
- Unusual changes in vision such as blurred sight
- Change in urine color, possibly indicating liver damage
- Symptoms pointing to heart failure like shortness of breath even during mild exertion; swelling or rapid weight gain; unusual tiredness; chest pain spreading to your jaw or shoulder.
If you suspect that Actos is causing any unusual symptoms, it's crucial that you consult your healthcare provider immediately.
Contraindications for Metformin and Actos?
Just like most diabetes medications, both Metformin and Actos may cause side effects in some people. If you notice any serious symptoms such as severe stomach pain, unusual tiredness or breathlessness, yellowing of the skin/eyes (jaundice), dark urine or changes in vision, it's critical to seek immediate medical attention.
Neither Metformin nor Actos should be taken if you have severe kidney disease or are on dialysis. Always inform your healthcare provider about all the medicines you take; certain drugs require a period of time to clear from your system to prevent hazardous interactions with Metformin and Actos.
Furthermore, while taking these medications closely monitor for signs of heart failure including unexpected weight gain, swelling hands/ankles/feet and trouble breathing. These drugs can sometimes lead to lactic acidosis - a rare but serious metabolic complication that can occur due to metformin accumulation during treatment with metformin-containing products.
How much do Metformin and Actos cost?
For the brand name versions of these drugs:
- The price of 60 tablets of Actos (30 mg) averages around $600, which works out to about $20 per day.
- The price for 100 tablets of Glucophage (the brand name version of metformin), at a dose strength of 500 mg, falls between $270 and $400. This translates to roughly $.80-$1.33 per day.
Thus, if you're taking typical doses for type II diabetes treatment (i.e., up to 2000mg/day for Metformin or up to 45mg/day for Actos), then Glucophage is less expensive on a per-day basis than Actos. Nonetheless, cost should not be the primary consideration in determining which drug is right for your condition.
For generic versions:
- Generic pioglitazone (Actos) costs significantly less with prices ranging from as low as $.50–$2 per tablet depending on dosage amount and where it's purchased.
- Generic metformin is available in packs ranging from 60 -180 tablets with costs starting as low as $.10-.40 cents per tablet depending on the exact formulation and location purchased.
Again remember that while cost can be an important factor when considering medication options, effectiveness, possible side effects and overall health goals should also be considered.
Popularity of Metformin and Actos
Metformin, in generic form as well as brand names such as Glucophage, was estimated to have been prescribed to about 78 million people in the US in 2017. Metformin accounted for just over 50% of prescriptions for type-2 diabetes treatment in the US. It is often the first-line medication recommended for patients with type-2 diabetes due to its effectiveness and relatively few side effects.
Pioglitazone, including brand versions such as Actos, was used by approximately 2.3 million Americans during that same year. In the United States, pioglitazone accounts for around 5% of overall prescriptions given out for type-2 diabetes management. Although it's not quite as common or widely prescribed as metformin mainly due to potential side effects like weight gain and possible increased risk of bladder cancer; however, it remains a valuable option when other treatments aren't enough or are contraindicated.
Conclusion
Both Metformin and Actos (pioglitazone) are widely used in the management of type 2 diabetes, with numerous clinical studies supporting their efficacy over placebo treatments. They can be combined to enhance glycemic control, but this requires careful consideration by a healthcare professional due to potential interactions and cumulative side effects. The two drugs work differently: metformin reduces hepatic glucose production and improves insulin sensitivity, while pioglitazone primarily increases peripheral insulin sensitivity.
Metformin is generally considered the first-line treatment option for most patients with type 2 diabetes due to its proven effectiveness, safety profile, weight neutrality, and cost-effectiveness. On the other hand, Actos might be added as an adjunct therapy in patients who do not achieve adequate glycemic control with metformin alone or those who cannot tolerate metformin.
Both medications are available as generics which presents cost savings especially for patients paying out-of-pocket. An adjustment period may also be necessary when starting either medication since full metabolic effects may take several weeks to manifest.
In terms of side effects profile; both drugs are usually well-tolerated although they have different sets of common adverse events. Metformin's most common side effects include gastrointestinal upset while Actos has been linked with weight gain and fluid retention. Patient monitoring is crucial during treatment initiation or up-titration phase for any signs of intolerance or possible serious adverse reactions such as lactic acidosis (for metformin) or heart failure exacerbation (for pioglitazone).
Other Trials to Consider
Popular Categories
Refrences
- Krentz, A. J., & Bailey, C. J. (2005). Oral Antidiabetic Agents. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200565030-00005
- Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., … Shulman, G. I. (2014, May 21). Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature. Springer Science and Business Media LLC.http://doi.org/10.1038/nature13270
- Waugh, J., Keating, G. M., Plosker, G. L., Easthope, S., & Robinson, D. M. (2006). Spotlight on Pioglitazone in Type 2 Diabetes Mellitus1. Treatments in Endocrinology. Springer Science and Business Media LLC.http://doi.org/10.2165/00024677-200605030-00006
- Tan, M., Johns, D., González Gálvez, G., Antúnez, O., Fabián, G., Flores-Lozano, F., … Herz, M. (2004, May). Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trial. Clinical Therapeutics. Elsevier BV.http://doi.org/10.1016/s0149-2918(04)90068-9
- Paul, M. (2011, December 28). Mechanismen und klinische Wirksamkeit von Pioglitazon als neues Prinzip in der Behandlung des Typ-2-Diabetes. Arzneimittelforschung. Georg Thieme Verlag KG.http://doi.org/10.1055/s-0031-1300511
- Schwartz, S. L., Wu, J. F., & Berner, B. (2006, March 24). Metformin extended release for the treatment of Type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. Informa UK Limited.http://doi.org/10.1517/14656566.7.6.803
- Le, S., & Lee, G. C. (2019, May 23). Emerging Trends in Metformin Prescribing in the United States from 2000 to 2015. Clinical Drug Investigation. Springer Science and Business Media LLC.http://doi.org/10.1007/s40261-019-00799-0
- Vaccaro, O., Masulli, M., Nicolucci, A., Bonora, E., Del Prato, S., Maggioni, A. P., … Agrusta, M. (2017, November). Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial. The Lancet Diabetes & Endocrinology. Elsevier BV.http://doi.org/10.1016/s2213-8587(17)30317-0
- Gaviria-Mendoza, A., Sánchez-Duque, J. A., Medina-Morales, D. A., & Machado-Alba, J. E. (2018, April). Prescription patterns and costs of antidiabetic medications in a large group of patients. Primary Care Diabetes. Elsevier BV.http://doi.org/10.1016/j.pcd.2017.11.002